baber/WOPTO huggingface dataset:
Patent AU-2011331901-A1 (AU)
Title: Anti-inflammatory compositions
Inventor: KO SAI YING
IPC: A61P29/00
Filed: 2011-11-09
Abstract: Provided herein are methods for the treatment of abnormal inflammation and inflammatory conditions comprising mucosal administration of an effective amount of an interleukin (e.g.IL-2) or a fragment or derivative thereof. Also provided herein are pharmaceutical compositions for mucosal administration for the treatment of abnormal inflammation and inflammatory conditions, the composition comprising said interleukin or fragment or derivative.
Patent AU-2011337104-A1 (AU)
Title: Method for controlling sharing of participant identity in a group communication session
Inventor: DROZT PETER M
IPC: H04W4/10
Filed: 2011-10-28
Abstract: A system and methods for increasing the granularity of privacy control in a group communication session are presented. A privacy rule is established for a participant in the session. The privacy rule specifies for different identity sharing triggers whether the participant identity is to be shared with other participants in the session. The privacy of the participant is able to be different dependent on the particular identity sharing trigger. The privacy rule is set by participant initiating the session, a separate server, or the participant. In the last case, the participant is able to specify privacy for a media or data stream when requesting the floor to transmit the stream. The identity of the participant is automatically modified dependent on session context information.
Patent AU-2011343954-A1 (AU)
Title: Melanoma treatments
Inventor: YAO YIHONG
IPC: C12Q1/68
Filed: 2011-12-14
Abstract: The disclosure provides methods for treating melanoma with an improving therapeutic effectiveness of drugs and reducing drug toxicity. Specifically, the disclosure provides personalized treatments of melanoma that optimize the therapeutic effect of a drug based on identifying the presence, absence or amount of a biomarker in a subject having the melanoma to whom an anti-cancer drug has been administered. Further disclosed are microRNA biomarkers that can be used for optimizing therapeutic efficacy of treating melanoma in a subject.
Patent AU-2011365350-A1 (AU)
Title: Hydrometallurgical method for the recovery of zinc in a sulphur medium starting from sulphudic zinc concentrates
Inventor: TAMARGO GARCIA FRANCISCO JOSE
IPC: C22B1/02
Filed: 2011-04-15
Abstract: The invention relates to a method wherein the zinc concentrate is subjected to the following steps: a. roasting at least one part of the zinc concentrate; b. neutral leaching, wherein the zinc oxide is dissolved; c. acid leaching, wherein the zinc ferrites are leached; d. reducing the Fe
Patent AU-2012203052-A1 (AU)
Title: Slew bearing system
Inventor: CRAIG JEFF
IPC: F16C19/34
Filed: 2012-05-24
Abstract: Abstract A method of monitoring wear of a slew bearing system comprising: (a) assembling a slew bearing system comprising: (1) a first bearing ring and a second bearing ring concentrically positioned relative to each other forming at least upper and lower raceways, (2) a plurality of bearing rollers positioned in each raceway between the first bearing ring and the second bearing ring, and (3) an index system having a first reference connected with the first bearing ring and positioned relative to a second reference on the second bearing ring to provide a measurable distance between the first reference and the second reference, where the measurable distance changes with wear of the slew bearing system; and (b) monitoring a change in the measurable distance between the first reference and the second reference to monitor wear of the slew bearing system.
Patent AU-2012203364-A1 (AU)
Title: Adjustable lift cord anchor for movable rails in coverings for architectural openings
Inventor: SPRAY JEFFREY L
IPC: A47H3/00
Filed: 2012-06-07
Abstract: An adjustable anchor (20) for anchoring a lift cord (32) in a movable rail (28) of a covering (22) for an architectural opening includes a housing (36) which is releasably positionable interiorly of the movable rail (28) in alignment with a lift cord (32) for the covering (22) with the anchor (20) including a rotatable drum (38) within the housing (36) and around which the lift cord (32) can be wrapped or unwrapped by rotating movement of the drum (38) with a tool (34). Two distinct systems are provided for releasably securing the drum (38) in any selected position to retain the amount of lift cord (32) wrapped therearound with the two systems acting in mutually perpendicular planes for reliable anchoring of the lift cord (32). Fig. 1 3 2 Fig. 2 {34
Patent AU-2012210547-A1 (AU)
Title: Process for the preparation of pyrazole carboxylic acid amide
Inventor: TERINEK MIROSLAV
IPC: C07D231/14
Filed: 2012-01-25
Abstract: The invention relates to a process for the preparation of 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide by acylating the oxime oxygen of the compound of formula (VIII), in the presence of a solvent and an acylating agent of formula (XI) R
Patent AU-2012217519-A1 (AU)
Title: Method, node device, and system for establishing label switched path
Inventor: LUO YANXING
IPC: H04L47/724
Filed: 2012-02-13
Abstract: The present invention relates to the technical field of telecommunications, and discloses a method, node device, and system for establishing a label switched path. The method comprises: a connection establishment request transmitted from a source node to a destination node is received, said request carrying bandwidth requests corresponding to different conditions, and each bandwidth request corresponding to a condition; according to the bandwidth requests corresponding to the different conditions, bandwidth resources are correspondingly reserved from the remaining sub-bandwidths corresponding to different conditions in own link, thereby establishing a connection between the source node and the destination node. In embodiments of the present invention, an initiated connection establishment request carries different conditions and the bandwidth requests corresponding to the different conditions, so that a node on a label switched path can reserve bandwidth information according to its own characteristics, thereby ensuring maximum utilization of bandwidth resources without compromising link reliability.
Patent AU-2012221766-A1 (AU)
Title: Detonation of explosives
Inventor: MULLER ELMAR
IPC: F42B3/12
Filed: 2012-02-20
Abstract: An explosives detonator system (10) comprises a detonator housing (13) within which is provided a detonation circuit (17) that comprises a conductive pathway (16) having a fuse head (14) integrated therewith such that the conductive pathway (16) passes along both electrodes and a resistive bridge of the fuse head (14). An uncharged chargeable voltage source (12) is also integrated with the detonation circuit (17) and is electrically sensitive to a charging property which is included in a charging signal. Exposure to the charging property charges the voltage source (12), thereby rendering it capable of generating a potential difference between the electrodes at least to equal the breakdown voltage of the resistive bridge. The charging property is any one or more of a charging light pulse, a charging temperature, a charging pressure and a charging radio frequency.
Patent AU-2012237899-A1 (AU)
Title: Site-directed mono-substituted PEGylated Exendin analog and preparation method therefor
Inventor: YUE PENG
IPC: C07K14/575
Filed: 2012-03-05
Abstract: Disclosed are a PEGylated compound obtained by site-directed mono-substitution of any amino group in the structure of an Exendin analog, a preparation method therefor, and a use thereof. In the present invention, a stable protection group Dde (N-α-1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl) is used, so that multi-substitution side reactions caused by the use of a labile protection group can be avoided, and preparation of the mono-substituted PEGylated Exendin analog with a high yield at a low reaction molar ratio can be achieved.
Patent AU-2012242646-A1 (AU)
Title: Remote data monitoring and collection system with multi-tiered analysis
Inventor: FAHEY MICHAEL
IPC: G16H40/67
Filed: 2012-04-13
Abstract: A system collects and stores data from a source at a high resolution and/or a high data rate("more detailed data") and sends a low-resolution and/or downsampled version of the data ("less detailed data") to a remote server via a wireless network. The server automatically analyzes the less detailed data to detect an anomaly, such as an arrhythmia, earthquake or failure of a structural member. A two-tiered analysis scheme is used, where the first tier is less specific than the second tier. If the first tier analysis detects or suspects the anomaly, the server signals the data collector to send more detailed data that corresponds to a time period associated with the anomaly. The more specific second tier analyses the more detailed data to verify the anomaly. The server may also store the received data and make it available to a user, such as via a graphical or tabular display.
Patent AU-2012249643-A1 (AU)
Title: Method for volumetric reduction of organic liquids
Inventor: GRANT GAVIN
IPC: B01D61/00
Filed: 2012-04-26
Abstract: Methods are provided for the volumetric reduction of organic liquids. The methods comprise admixing a porous matrix material with an organic liquid to produce a mixture, forcing oxidant through the mixture, and initiating a self-sustaining smoldering combustion of the mixture. Additional embodiments aggregate the organic liquid or porous matrix material or mixture thereof in an impoundment such as a reaction vessel, lagoon or matrix pile. Further embodiments utilize at least one heater to initiate combustion and at least one air supply port to supply oxidant to initiate and maintain combustion. Yet further embodiments comprise the batch addition of a fuel additive to the aggregate prior to smoldering to ensure that the ensuing smoldering combustion is self-sustaining or of the required temperature to reduce or remove other contaminants in the matrix or organic liquid such as heavy metals or asbestos.
Patent AU-2012253615-A1 (AU)
Title: Compositions and methods for treating Alzheimer's disease
Inventor: ALAM JOHN JAHANGIR
IPC: A01N43/90
Filed: 2012-05-09
Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
Patent AU-2012264733-A1 (AU)
Title: System and method for managing parking passes while limiting the parking pass depending on parking passes previously provided to a user
Inventor: SILVANT JEROME
IPC: G07B15/02
Filed: 2012-05-30
Abstract: The invention relates to a method for managing parking passes via a system for managing parking passes, including at least one device for dispensing a parking pass, and a server for centralizing the parking passes, the centralization server being connected to the or each dispensing device via a data link, said method including the following steps: a user inputting an identification code to the dispensing device (12); the dispensing device outputting (150) a parking pass to the user; and recording (160) the parking pass in a file stored in a memory of the centralization server. The method further includes modifying a subsequent parking pass, for each identification code, depending on the previously output parking passes that were recorded in the recording file, each modification being associated with a parking area and a time interval.
Patent AU-2012282916-A1 (AU)
Title: Method and system for fault recovery in a branched optical network
Inventor: MU RUOMEI
IPC: H04L12/28
Filed: 2012-07-05
Abstract: A method of managing fault recovery in a trunk-branched OADM network may include determining that an optical power level over data channels of a first communications link between a first and a second terminal of the branched optical network exceeds an optical power limit. The method may further include increasing optical power sent over spare channels of the first communications link to a first level at which the optical power level over the data channels decreases to a second level below the optical power limit.
Patent AU-2012295779-A1 (AU)
Title: Medical composition containing stauntonia hexaphylla extract
Inventor: CHOI CHUL YUNG
IPC: A61P29/00
Filed: 2012-05-16
Abstract: The present invention relates to a fever medicine containing a Stauntonia hexaphylla leaf extract as an active ingredient. The Stuantonia hexaphylla leaf extract according to the present invention does not have cytotoxicity, and is completed by verifying a superior fever alleviation effect even when compared to existing fever medicines having fever alleviation effects. The composition for alleviating fever containing the Stauntonia hexaphylla leaf extract as the active ingredient has an excellent fever alleviation effect.
Patent AU-2012296235-A1 (AU)
Title: Sweetener composition
Inventor: VALLINI VERONICA
IPC: A23L27/30
Filed: 2012-08-13
Abstract: There is described a substantially liquid sweetener composition comprising at least 80 wt% of water, from 9 wt% to 12 wt% of sodium cyclamate, from 4 wt% to 6 wt% of " sodium saccharine, from 1 wt% to 2 wt% of potassium acesulfame; the sweetening components of the composition act synergically in such a manner as to increase its sweetening power.
Patent AU-2012302039-A1 (AU)
Title: New reactive surfactants for emulsion polymerization, pigment dispersion, and UV coatings
Inventor: PALMER CHARLES FRANCIS
IPC: C09K23/52
Filed: 2012-08-29
Abstract: The present invention provides reactive surfactants of the formula R
Patent AU-2012302451-A1 (AU)
Title: Terminal and application management method thereof
Inventor: HONG YOUNG KI
IPC: G06F9/44
Filed: 2012-08-30
Abstract: A terminal and application synchronization method is provided for simultaneously updating multiple applications. The application synchronization method includes acquiring a synchronization timing of a previously registered synchronization target application or a common synchronization timing of previously registered synchronization target applications, when an application to be synchronized is added; and adjusting the synchronization timing of the added application in consideration of the previous synchronization timing or the common synchronization timing.
Patent AU-2012310328-A1 (AU)
Title: Anti-Tumor Necrosis Factor-alpha agents and uses thereof
Inventor: CASTANHEIRA AIRES DA SILVA FREDERICO NUNO
IPC: C07K16/24
Filed: 2012-09-19
Abstract: The present invention relates to polypeptides comprising one or more antibody single domains, or antigen-binding fragments thereof, directed against Tumor Necrosis Factor-alpha, in particular, two light chain variable domains in dimeric form, where the dimer has high solubility. It also relates to methods of using anti-Tumor Necrosis Factor-alpha polypeptides in treating inflammatory disorders, including rheumatoid arthritis. Compositions and methods for enhancing therapeutic potential of anti-Tumor Necrosis Factor-alpha polypeptides are provided, including linking the polypeptide to an albumin-binding domain and/or de-immunizing the polypeptide, to provide therapeutic agents with good solubility, enhanced serum half-life, and/or reduced immunogenicity, while substantially maintaining the specific binding properties of the anti-Tumor Necrosis Factor-alpha polypeptides.
Patent AU-2012318246-A1 (AU)
Title: Anti-KDR antibodies and methods of use
Inventor: KE YAOHUANG
IPC: C12N15/00
Filed: 2012-11-01
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date W O 2013/067098 Al 10 May 2013 (10.05.2013) WI PO I P CT (51) International Patent Classification: (74) Agents: URVATER, Julie A. et al.; Cooley LLP, 777 C07K16/28 (2006.01) A61K39/395 (2006.01) 6th Street, NW, Suite 1100, Washington, District of C12N15/13 (2006.01) A61P 35/00 (2006.01) Columbia 20001 (US). (21) International Application Number: (81) Designated States (unless otherwise indicated, for every PCT/US2012/062929 kind of national protection available): AE, AG, AL, AM, (22) International Filing Date: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, ( November 2012 (01.11.2012) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, Fl, GB, GD, GE, GH, GM, GT, (25) Filing Language: English HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, (26) Publication Language: English ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (30) Priority Data: NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, 61/554,758 2 November 2011 (02.11.2011) US RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, 61/609,581 12 March 2012 (12.03.2012) US TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (71) Applicant: APEXIGEN, INC. [US/US]; 863 Mitten Road, Suite 103, Burlingame, California 94010 (US). (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (72) Inventors: KE, Yaohuang; 2323 - 18th Avenue, San Fran- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, cisco, California 94116 (US). LEE, Sum Wai Pierre; UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 1215 - 21st Avenue, San Francisco, California 94122 (US). TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, ZHANG, Yongke; 3119 Stockton Place, Palo Alto, Cali- EE, ES, Fl, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, fornia 94303 (US). YU, Guo-Liang; 1025 Tournament MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, Drive, Hillsborough, California 94010 (US). ZHU, Weim- TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, in; 1216 Toyon Drive, Millbrae, California 94030 (US). ML, MR, NE, SN, TD, TG). [Continued on next page] (54) Title: ANTI-KDR ANTIBODIES AND METHODS OF USE (57) Abstract: The present invention 5 mg/kg, ip, 3/week x 8 doses provides anti-KDR monoclonal anti bodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment 1200- of a variety of cancers, rheumatoid arthritis, diabetic retinopathy and other diseases associated with aberrant 900- VEGF or KDR expression and/or activ -a- PBS Control i 600- -- Avastin ; -v- APX004 15 18 21 24 27 30 33 36 39 42 45 Days post tumor Inoculation
Patent AU-2012318259-A1 (AU)
Title: Hemostatic compositions
Inventor: HARKAMP KATHARINA
IPC: A61K38/00
Filed: 2012-10-10
Abstract: - 24 Abstract The invention discloses a hemostatic composition comprising chitin or a water insoluble chitin derivative, especially water insoluble chitosan, in particulate form, wherein the composition is present in paste form.
Patent AU-2012323349-A1 (AU)
Title: R(+)-N-formyl-propargyl-aminoindan
Inventor: SAFADI MUHAMMAD
IPC: C07C231/02
Filed: 2012-10-09
Abstract: The subject invention provides R (+) -N-formyl-propargyl- aminoindan and a composition containing N-propargyl-1 (R) -aminoindan or a pharmaceutically acceptable salt thereof, and a compound of R (+) -N-formyl-propargyl-aminoindan.
Patent AU-2012344085-A1 (AU)
Title: Method and system for controlling items on a production/distribution line
Inventor: COLLOMBET YVAN
IPC: G06Q50/28
Filed: 2012-11-23
Abstract: The disclosed method, and corresponding system, for controlling items on a production/distribution line relies on secure identification of items transported arranged according a given disposition along a transport path at different sites of the line and checking operation according to a protocol which allows reducing processing load while ensuring high reliability.
Patent AU-2012350654-A1 (AU)
Title: Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
Inventor: HOHLBAUM ANDREAS
IPC: G01N33/68
Filed: 2012-12-12
Abstract: The present disclosure relates to methods of treating, ameliorating or preventing a disorder comprising administering a therapeutically effective amount of a composition to a subject in need thereof, which composition contains a lipocalin mutein or a fragment or a variant thereof capable of increasing the bioavailability of iron in the subject.
Patent AU-2012351535-A1 (AU)
Title: Cohesive thin liquids to promote safe swallowing in dysphagic patients
Inventor: BURBIDGE ADAM
IPC: A23L29/269
Filed: 2012-12-17
Abstract: Nutritional products having improved cohesiveness for promoting safer swallowing of food boluses for patients having swallowing conditions are provided as well as methods of making and using such products. The nutritional products may include nutritional compositions and high molecular weight, water-soluble polymers such that the nutritional products have extensional viscosities that provide improved cohesiveness to the nutritional products. Methods of administering such nutritional products to patients having impaired swallowing ability and/or dysphagia are also provided.
Patent AU-2012358373-A1 (AU)
Title: Processing of biomass materials
Inventor: MEDOFF MARSHALL
IPC: C12P19/14
Filed: 2012-12-20
Abstract: Provided are methods of inducing enzymes, and for treating cellulosic and lignocellulosic biomass with the enzyme.
Patent AU-2012361581-A1 (AU)
Title: Effect potentiator for antitumor agents
Inventor: FUJITA HIDENORI
IPC: A61K31/4745
Filed: 2012-12-27
Abstract: An antitumor effect potentiator for other antitumor agents, which contains, as an active ingredient, an acylthiourea compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. (In the formula, R
Patent AU-2012376220-A1 (AU)
Title: Ferrule for optical fiber connector having a compliant structure for clamping alignment pins
Inventor: LI SHUHE
IPC: G02B6/38
Filed: 2012-10-11
Abstract: A compliant structure clamps the alignment pins to accurately and precisely locate the alignment pins. The compliant structure supports the alignment pins with no clearance. The compliant structure is defined by at least a flexure in the form of a cantilevered structure extending at a side of the ferrule. The cantilevered structure, with or without a complementary support structure, defines a space in which an alignment pin can be supported. The flexure may be defined by one or more slots provided on the body of the ferrule to facilitate bending of the extended cantilevered structure. In another embodiment, the ferrule comprises a ferrule insert having grooves for supporting optical fibers, and a ferrule frame that supports the ferrule insert and alignment pins. The compliant structure is provided on the frame. In a further embodiment, the ferrule insert is provided with optical fiber grooves at its perimeter.
Patent AU-2013200810-A1 (AU)
Title: EGFR Mutations
Inventor: SESHAGIRI SOMASEKAR
IPC: A61K38/16
Filed: 2013-02-14
Abstract: The present invention relates to mutations in Epidermal Growth Factor Receptor (EGFR) and methods of detecting such mutations as 5 well as prognostic methods for identifying tumors that are susceptible to anticancer therapy such as chemotherapy and/or kinase inhibitor treatment. The methods involve determining the presence of a mutated (EGFR) gene or mutated (EGFR) protein in a tumor sample whereby the presence of a mutated (EGFR) gene or protein indicates 10 the tumor is susceptible to treatment. 405948_1 (GHMatIOs) P71002.AU.2 14-Feb-13
Patent AU-2013202823-A1 (AU)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: A23K10/32
Filed: 2013-04-08
Abstract: PROCESSING BIOMASS Abstract Biomass (e.g. plant biomass, animal biomass, microbial, and municipal waste biomass) is processed to produce useful products, such as food products and amino acids.